Share on social:
LinkedIn
Twitter
Facebook
Share on social:
Study Led by John Mignone, M.D., Ph.D., Presented at the Heart Rhythm Society’s Annual Meeting. Key Findings Demonstrate Increased Survival for Patients Receiving Combined Device and 4-Class Medical Therapy.
Expansion leverages a custom module to help health systems identify patients eligible for lifesaving therapy
Use of artificial intelligence technology efficiently identifies eligible patient candidates for pivotal clinical trial; program launched at The Christ Health Network
© 2022 egnite, Inc. All Rights Reserved. egnite, egnite Inc., and the stylized logo are trademarks of egnite, Inc. All other trademarks are property of their respective owners.